← FDA Drug Approvals (Drugs@FDA)

TEGSEDI

NDA · New Drug Application · Sponsor: AKCEA THERAPS · Approved 2018-10-05

Drug application

FDA Application #

NDA211172

Application type

New Drug Application

Brand name

TEGSEDI

Generic name

Inotersen Sodium

Active ingredients

INOTERSEN SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

AKCEA THERAPS

First approval

2018-10-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown